Segueix
Niccolò Bitto
Niccolò Bitto
IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, SC Medicina - Emostasi e Trombosi
Correu electrònic verificat a policlinico.mi.it
Títol
Citada per
Citada per
Any
Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis
V La Mura, S Braham, G Tosetti, F Branchi, N Bitto, M Moia, ...
Clinical Gastroenterology and Hepatology 16 (7), 1146-1152. e4, 2018
1022018
Coagulation, microenvironment and liver fibrosis
N Bitto, E Liguori, VL Mura
Cells 7 (8), 85, 2018
632018
Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome
M Magaz, H Giudicelli-Lett, O Nicoară-Farcău, N Rajoriya, A Goel, ...
Transplantation 107 (6), 1330-1340, 2023
222023
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
M Magaz, H Giudicelli-Lett, JG Abraldes, O Nicoară-Farcău, F Turon, ...
Journal of Hepatology 82 (1), 72-83, 2025
16*2025
Simvastatin prevents liver microthrombosis and sepsis induced coagulopathy in a rat model of endotoxemia
V La Mura, N Gagliano, F Arnaboldi, P Sartori, P Procacci, L Denti, ...
Cells 11 (7), 1148, 2022
152022
Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy
V La Mura, N Bitto, C Capelli, C Caputo, S Siboni, S Arcudi, A Ciavarella, ...
Blood Advances 7 (19), 5817-5824, 2023
82023
Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges
V La Mura, N Bitto, A Tripodi
Expert Review of Hematology 15 (12), 1031-1044, 2022
72022
Improving management of portal hypertension: The potential benefit of non-etiological therapies in cirrhosis
N Bitto, G Ghigliazza, S Lavorato, C Caputo, V La Mura
Journal of clinical medicine 12 (3), 934, 2023
62023
Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis
N Bitto, F Salerno, A Tripodi, V La Mura
Journal of Hepatology 63 (1), 277-278, 2015
52015
AB0, von Willebrand factor/factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit?
N Bitto, G Tosetti, V La Mura, M Primignani
Liver International 40 (7), 1788-1789, 2020
32020
Clinical presentation and etiological spectrum of idiopathic non-cirrhotic portal hypertension (INCPH): data from the Italian Registry
M Primignani, G Tosetti, V La Mura, N Bitto, L Turco, M Bianchini, S Gioia, ...
Digestive and Liver Disease 51, e49, 2019
12019
Non-neoplastic portal vein thrombosis in HCV cirrhosis: the weight of inflammation on a fragile hemostatic balance
N Bitto, V La Mura
AME Medical Journal 2 (10), 2017
12017
Gene therapy in hemophilia: the dawn of a new era
R Gualtierotti, A Giachi, N Bitto, V La Mura, F Peyvandi
Research and Practice in Thrombosis and Haemostasis, 102640, 2024
2024
OC 52.2 Residual Burden of Liver Disease After HCV-Clearance in Hemophilia: AWord of Caution in the Era of Gene Therapy
V La Mura, N Bitto, C Capelli, C Caputo, S Siboni, S Arcudi, A Ciavarella, ...
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
Is non-alcoholic fatty liver disease a prothrombotic risk factor?
N Bitto, V La Mura, AL Fracanzani, A Tripodi
Bleeding, Thrombosis and Vascular Biology 2 (2), 2023
2023
Liver health in patients with hemophilia: Residual risk factors of liver-related complications after HCV-clearance
V La Mura, N Bitto, C Capelli, C Caputo, S Siboni, S Arcudi, A Ciavarella, ...
Digestive and Liver Disease 55, S65-S66, 2023
2023
Liver Health in Patients with Hemophilia: Residual Risk Factors of Liver-Related Complications after HCV Clearance
V La Mura, N Bitto, C Capelli, SM Siboni, S Arcudi, A Ciavarella, ...
Blood 140 (Supplement 1), 8440-8441, 2022
2022
Factor VIII/protein C and not ADAMTS13/VWF: Ag ratio is a prognostic risk factor for patients with cirrhosis and low MELD score
N Bitto, G Tosetti, A Tripodi, I Mancini, L Baronciani, C Valsecchi, ...
Digestive and Liver Disease 52, e13-e14, 2020
2020
ANTITHROMBOTIC PROPERTIES OF SIMVASTATIN ON THE ENDOTHELIUM AND PREVENTION OF LIVER MICROTHROMBOSIS AFTER EXPOSURE TO LIPOPOLYSACCHARIDE
V La Mura, N Gagliano, F Arnaboldi, P Sartori, P Procacci, E Liguori, ...
HEPATOLOGY 70, 69A-69A, 2019
2019
Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis
V La Mura, A Tripodi, N Bitto, G Tosetti, V Chantarangkul, L Baronciani, ...
Digestive and Liver Disease 49 (1), e34, 2017
2017
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20